HIGHLY CONSTRAINED GLUCAGON-LIKE PEPTIDE-1 ANALOGUES WITH IMPROVED BIOLOGICAL ACTIVITY AND ENZYME STABILITY

被引：0
|
作者：
Murage, E. [1 ]
Gao, G. [1 ]
Bisello, A. [1 ]
Ahn, J. [1 ]
机构：
[1] Univ Texas Dallas, Dallas, TX 75230 USA
来源：
BIOPOLYMERS | 2009年 / 92卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：358 / 358
页数：1
相关论文
共 50 条
  • [1] Synthesis and Biological Activity Studies of Glucagon-Like Peptide-1 Analogues
    Chi, Yu-Shi
    Huang, Wen-Long
    Zhang, Hui-Bin
    Zhou, Jin-Pei
    Zhou, Ying-Hong
    Ni, Shuai-Jian
    Qian, Hai
    [J]. CHINESE JOURNAL OF ORGANIC CHEMISTRY, 2008, 28 (11) : 1925 - 1931
  • [2] Biological activities of glucagon-like peptide-1 analogues in vitro and in vivo
    Xiao, Q
    Giguere, J
    Parisien, M
    Jeng, W
    St-Pierre, SA
    Brubaker, PL
    Wheeler, MB
    [J]. BIOCHEMISTRY, 2001, 40 (09) : 2860 - 2869
  • [3] Dipeptidyl peptidase IV resistant analogues of glucagon-like peptide-1 which have extended metabolic stability and improved biological activity
    C. F. Deacon
    L. B. Knudsen
    K. Madsen
    F. C. Wiberg
    O. Jacobsen
    J. J. Holst
    [J]. Diabetologia, 1998, 41 : 271 - 278
  • [4] Dipeptidyl peptidase IV resistant analogues of glucagon-like peptide-1 which have extended metabolic stability and improved biological activity
    Deacon, CF
    Knudsen, LB
    Madsen, K
    Wiberg, FC
    Jacobsen, O
    Holst, JJ
    [J]. DIABETOLOGIA, 1998, 41 (03) : 271 - 278
  • [5] Influence of Selective Fluorination on the Biological Activity and Proteolytic Stability of Glucagon-like Peptide-1
    Meng, He
    Krishnaji, Subrahmanian Tarakkad
    Beinborn, Martin
    Kumar, Krishna
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (22) : 7303 - 7307
  • [6] A synthetic glucagon-like peptide-1 analog with improved plasma stability
    Ritzel, U
    Leonhardt, U
    Ottleben, M
    Rühmann, A
    Eckart, K
    Spiess, J
    Ramadori, G
    [J]. JOURNAL OF ENDOCRINOLOGY, 1998, 159 (01) : 93 - 102
  • [7] Biosynthesis and antidiabetic activity of oral cyclic glucagon-like peptide-1 analogues
    Liu, Min-zhi
    Wang, Wei
    Peng, Jun
    Shen, Zhu-fang
    [J]. ACTA PHARMACOLOGICA SINICA, 2013, 34 : 130 - 130
  • [8] Glucagon and glucagon-like peptide-1
    Livingston, JN
    Schoen, WR
    [J]. ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 34, 1999, 34 : 189 - 198
  • [9] Long acting peptide (LAP™) analogues of glucagon-like peptide-1
    Habi, Abdekrim
    Abran, Daniel
    Peri, Krishna G.
    Brubaker, Patricia
    Abribat, Thierry
    [J]. PEPTIDE REVOLUTION: GENOMICS, PROTEOMICS & THERAPEUTICS, 2004, : 623 - 624
  • [10] Can epicardial fat glucagon-like peptide-1 receptor open up to the cardiovascular benefits of glucagon-like peptide-1 analogues?
    Iacobellis, Gianluca
    [J]. POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2021, 131 (03): : 224 - 225
12345